# Sodium Phosphate Sprint Performance Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/sodium-phosphate-sprint-performance-randomized-trial-evidence-review
Category: evidence-review
Summary: Sodium Phosphate Sprint Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this f
Last reviewed: 2026-09-15
Reviewed by: Migaku Evidence Review
# Sodium Phosphate Sprint Performance Randomized Trial: What the Evidence Says

## Quick Answer

Sodium Phosphate Sprint Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials | systematic review | 1 | 2026-03-26 | 10.3389/fnut.2026.1818755 |
| Delaying task failure in high-intensity exercise: a Pi-afferent-effort framework for targeted sports nutrition | narrative review | 3 | 2026-07-30 | 10.1080/15502783.2026.2711031 |

## What The Sources Report

- This review excluded supplements where the proposed ergogenic mechanism did not involve failure at high intensity; studies with primarily clinical evidence and not focused on sports performance; or when available evidence did not support a clear mechanistic link with the framework. [Stout Jeffrey R. (2026); evidence level 3]
- The review did not perform risk-of-bias assessments or grading of evidence, nor did it pool data using meta-analysis; therefore, any conclusions drawn should be regarded as hypothesis-generating rather than exhaustive. [Stout Jeffrey R. (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For sodium phosphate sprint performance randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Liang Weibao (2026). No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1818755. PMCID: PMC13061858. PMID: 41971372. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061858/
- Stout Jeffrey R. (2026). Delaying task failure in high-intensity exercise: a Pi-afferent-effort framework for targeted sports nutrition. DOI: 10.1080/15502783.2026.2711031. PMCID: PMC13425531. PMID: 42530633. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13425531/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.